Ö. ÖZDEMİR IŞIK Et Al. , "Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome," International Journal of Rheumatic Diseases , vol.27, no.1, 2024
ÖZDEMİR IŞIK, Ö. Et Al. 2024. Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome. International Journal of Rheumatic Diseases , vol.27, no.1 .
ÖZDEMİR IŞIK, Ö., Karadag, D. T., Tekeoglu, S., YAZICI, A., Cefle, K., & ÇEFLE, A., (2024). Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome. International Journal of Rheumatic Diseases , vol.27, no.1.
ÖZDEMİR IŞIK, ÖZLEM Et Al. "Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome," International Journal of Rheumatic Diseases , vol.27, no.1, 2024
ÖZDEMİR IŞIK, ÖZLEM Ö. Et Al. "Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome." International Journal of Rheumatic Diseases , vol.27, no.1, 2024
ÖZDEMİR IŞIK, Ö. Et Al. (2024) . "Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome." International Journal of Rheumatic Diseases , vol.27, no.1.
@article{article, author={ÖZLEM ÖZDEMİR IŞIK Et Al. }, title={Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome}, journal={International Journal of Rheumatic Diseases}, year=2024}